Indoco Remedies · NSE: INDOCO · BSE: 532612
Q3 FY20 results · Oct–Dec 2019
Indoco Remedies reported revenue from operations of ₹289.35 crore and net profit of ₹9.10 crore for Q3 FY20 (Oct–Dec 2019), on a consolidated basis.
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 289.35 | — | — | 292.57 | −1.1% |
| Other income | 0.72 | — | — | 0.58 | +24.1% |
| Total income | 290.07 | — | — | 293.15 | −1.1% |
| Profit before tax | 11.07 | — | — | 9.80 | +13.0% |
| Net profit for the period | 9.10 | — | — | 7.81 | +16.5% |
| EPS, basic (₹) | 0.99 | — | — | 0.85 | +16.5% |
| Net margin (%) | 3.1 | — | 2.7 |
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 289.34 | 262.56 | +10.2% | 291.97 | −0.9% |
| Other income | 0.72 | 0.57 | +26.3% | 0.58 | +24.1% |
| Total income | 290.06 | 263.13 | +10.2% | 292.55 | −0.9% |
| Profit before tax | 11.32 | 3.90 | +190.3% | 9.31 | +21.6% |
| Net profit for the period | 9.34 | 5.34 | +74.9% | 7.33 | +27.4% |
| EPS, basic (₹) | 1.01 | 0.58 | +74.1% | 0.80 | +26.2% |
| Net margin (%) | 3.2 | 2.0 | 2.5 |
Consolidated
- Filed with BSE
- 23 Jan 2020, 15:58 IST
- Board meeting
- 23 Jan 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 23 Jan 2020, 15:58 IST
- Board meeting
- 23 Jan 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE